Related Experiment Videos
Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten
P Tapley1, N K Shevde, P A Schweitzer
1Ligand Pharmaceuticals Inc., San Diego, CA 92121, USA.
Abstract:
The mouse mutation viable motheaten (me(v)) results in defects in the expression and catalytic activity of the cytoplasmic protein tyrosine phosphatase known as hematopoietic cell phosphatase (HCP). This reduction in HCP activity leads to the aberrant regulation of several myeloid and lymphoid cell lineages, including substantial increases in numbers of granulocytes. The differentiation, proliferation, and survival of cells in this lineage are normally supported by granulocyte-colony stimulating factor (G-CSF). In this study we have determined the consequences of the loss of HCP activity in me(v)/me(v) mice on the response of bone marrow cells to G-CSF. Bone marrow from these mice exhibited substantial increases in clonogenic and proliferative responses to G-CSF. These enhanced activities of G-CSF correlated with an increase in the level of immature granulocytic, G-CSF receptor positive cells in the bone marrow. These results suggested the possibility that HCP may regulate the G-CSF receptor by a direct interaction. However, under conditions where the previously described interaction between the erythropoietin receptor and HCP was readily observed, HCP did not detectably associate with the G-CSF receptor.
Insights
Defects in hematopoietic cell phosphatase (HCP) activity in viable motheaten mice enhance granulocyte-colony stimulating factor (G-CSF) responses. This study investigates the impact of reduced HCP on myeloid cell development and G-CSF signaling pathways.
Area of Science:
- Immunology and Hematopoiesis
- Cell Signaling and Signal Transduction
Background:
- The viable motheaten (me(v)) mouse mutation impairs hematopoietic cell phosphatase (HCP) activity.
- Reduced HCP leads to dysregulation of myeloid and lymphoid cell lineages, notably increased granulocytes.
- Granulocyte-colony stimulating factor (G-CSF) is crucial for granulocyte differentiation, proliferation, and survival.
Purpose of the Study:
- To investigate the consequences of HCP loss on bone marrow cell responses to G-CSF in me(v)/me(v) mice.
- To explore the potential regulatory role of HCP in G-CSF receptor signaling.
Main Methods:
- Analysis of bone marrow cell responses to G-CSF in me(v)/me(v) mice.
- Assessment of clonogenic and proliferative capacities of bone marrow cells.
- Quantification of immature granulocytic, G-CSF receptor-positive cells.
- Investigation of potential physical association between HCP and the G-CSF receptor.
Main Results:
- me(v)/me(v) mouse bone marrow exhibited significantly enhanced clonogenic and proliferative responses to G-CSF.
- Increased G-CSF responsiveness correlated with elevated levels of immature, G-CSF receptor-positive granulocytes.
- HCP did not show detectable association with the G-CSF receptor, despite association with the erythropoietin receptor.
Conclusions:
- Loss of HCP activity potentiates G-CSF-driven granulopoiesis.
- The mechanism of HCP's influence on G-CSF signaling does not appear to involve direct physical interaction with the G-CSF receptor.
- Further research is needed to elucidate the precise molecular mechanisms by which HCP regulates G-CSF responsiveness.